| Nome |
# |
|
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014, file dd9e0c65-731c-1e9c-e053-3a05fe0a45ef
|
163
|
|
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV, file dd9e0c66-f79d-1e9c-e053-3a05fe0a45ef
|
84
|
|
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?, file dd9e0c67-09f3-1e9c-e053-3a05fe0a45ef
|
84
|
|
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates, file dd9e0c65-fba8-1e9c-e053-3a05fe0a45ef
|
78
|
|
Potential diagnostic properties of chest ultrasound in thoracic tuberculosis—A systematic review, file dd9e0c65-7247-1e9c-e053-3a05fe0a45ef
|
67
|
|
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015, file dd9e0c66-d6b6-1e9c-e053-3a05fe0a45ef
|
61
|
|
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients., file dd9e0c67-351b-1e9c-e053-3a05fe0a45ef
|
61
|
|
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study, file dd9e0c66-f8ad-1e9c-e053-3a05fe0a45ef
|
57
|
|
Focused ultrasound to diagnose HIV-associated tuberculosis (FASH) in the extremely resource-limited setting of South Sudan: a cross-sectional study, file dd9e0c66-e383-1e9c-e053-3a05fe0a45ef
|
56
|
|
Splenic abscesses as a first manifestation of Crohn's disease: A case report, file dd9e0c67-09fa-1e9c-e053-3a05fe0a45ef
|
56
|
|
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort, file dd9e0c67-131e-1e9c-e053-3a05fe0a45ef
|
56
|
|
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?, file dd9e0c66-fa65-1e9c-e053-3a05fe0a45ef
|
55
|
|
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy, file dd9e0c66-d198-1e9c-e053-3a05fe0a45ef
|
53
|
|
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study, file dd9e0c66-f266-1e9c-e053-3a05fe0a45ef
|
53
|
|
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine
evidence from the Italian MASTER Cohort., file dd9e0c67-0c4d-1e9c-e053-3a05fe0a45ef
|
53
|
|
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients, file dd9e0c67-1fe5-1e9c-e053-3a05fe0a45ef
|
53
|
|
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study, file dd9e0c67-01d1-1e9c-e053-3a05fe0a45ef
|
52
|
|
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?, file dd9e0c66-f796-1e9c-e053-3a05fe0a45ef
|
51
|
|
Predictors of therapy failure in newly diagnosed pulmonary tuberculosis cases in Beira, Mozambique., file dd9e0c64-edec-1e9c-e053-3a05fe0a45ef
|
50
|
|
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART, file dd9e0c65-8058-1e9c-e053-3a05fe0a45ef
|
50
|
|
Impact of Ebola outbreak on reproductive health services in a rural district of Sierra Leone: A prospective observational study, file dd9e0c66-e388-1e9c-e053-3a05fe0a45ef
|
50
|
|
Pathways of care for HIV infected children in Beira, Mozambique: Pre-post intervention study to assess impact of task shifting, file dd9e0c65-6a9f-1e9c-e053-3a05fe0a45ef
|
49
|
|
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus, file dd9e0c67-0e8a-1e9c-e053-3a05fe0a45ef
|
49
|
|
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study., file dd9e0c67-0a98-1e9c-e053-3a05fe0a45ef
|
48
|
|
Letter: chronic hepatitis C genotype 3 infection - still a hurdle toward a direct-acting anti-viral-induced HCV cure?, file dd9e0c67-3a3d-1e9c-e053-3a05fe0a45ef
|
48
|
|
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection, file dd9e0c69-1094-1e9c-e053-3a05fe0a45ef
|
48
|
|
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study, file dd9e0c63-e625-1e9c-e053-3a05fe0a45ef
|
47
|
|
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients, file dd9e0c63-e698-1e9c-e053-3a05fe0a45ef
|
47
|
|
The at risk child clinic (ARCC): 3 years of health activities in support of the most vulnerable children in Beira, Mozambique, file dd9e0c66-d6ba-1e9c-e053-3a05fe0a45ef
|
47
|
|
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice, file dd9e0c67-2388-1e9c-e053-3a05fe0a45ef
|
47
|
|
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program, file dd9e0c67-221f-1e9c-e053-3a05fe0a45ef
|
46
|
|
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia, file dd9e0c66-e975-1e9c-e053-3a05fe0a45ef
|
45
|
|
Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique, file dd9e0c67-3bf9-1e9c-e053-3a05fe0a45ef
|
45
|
|
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy, file dd9e0c66-d6b8-1e9c-e053-3a05fe0a45ef
|
44
|
|
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment, file dd9e0c67-2543-1e9c-e053-3a05fe0a45ef
|
44
|
|
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients, file dd9e0c64-e5d9-1e9c-e053-3a05fe0a45ef
|
42
|
|
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort, file dd9e0c67-222e-1e9c-e053-3a05fe0a45ef
|
42
|
|
PrEP in Italy: The time may be ripe but who’s paying the bill? A nationwide survey on physicians’ attitudes towards using antiretrovirals to prevent HIV infection, file dd9e0c67-3a40-1e9c-e053-3a05fe0a45ef
|
42
|
|
Liver fibrosis progression and clinical outcomes are intertwined: Role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCVcoinfected patients with detectable HCV-RNA A MASTER cohort study, file dd9e0c63-e69f-1e9c-e053-3a05fe0a45ef
|
41
|
|
Prevalence and predictors of malaria in human immunodeficiency virus infected patients in beira, mozambique, file dd9e0c66-f8b9-1e9c-e053-3a05fe0a45ef
|
41
|
|
HIV-1 coreceptor tropism: A syllogistic connection with the veterans aging cohort study index and the CD4/CD8 ratio, file dd9e0c66-d20e-1e9c-e053-3a05fe0a45ef
|
33
|
|
HCV and diabetes: Towards a 'sustained' glycaemic improvement after treatment with DAAs?, file dd9e0c6a-c789-1e9c-e053-3a05fe0a45ef
|
9
|
|
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen, file dd9e0c65-6651-1e9c-e053-3a05fe0a45ef
|
6
|
|
Local Food Resources to Fight Children Malnutrition and Infectious Diseases in Mozambique, file dd9e0c69-e43d-1e9c-e053-3a05fe0a45ef
|
6
|
|
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study, file dd9e0c6a-8873-1e9c-e053-3a05fe0a45ef
|
6
|
|
Limited Additive Diagnostic Impact of Isolated Gastrointestinal Involvement for the Triage of Children with Suspected COVID-19, file dd9e0c6b-4349-1e9c-e053-3a05fe0a45ef
|
3
|
|
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection, file dd9e0c6b-be74-1e9c-e053-3a05fe0a45ef
|
3
|
|
Low-Wage Agricultural Migrant Workers in Apulian Ghettos, Italy: General Health Conditions Assessment and HIV Screening, file 43682909-601e-452d-9f80-e739b91303d4
|
2
|
|
Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study., file dd9e0c62-7bb9-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c63-e627-1e9c-e053-3a05fe0a45ef
|
2
|
|
Tuberculosis and diabetes: Current state and future perspectives, file dd9e0c63-e8b7-1e9c-e053-3a05fe0a45ef
|
2
|
|
Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review, file dd9e0c63-e9a6-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c65-092a-1e9c-e053-3a05fe0a45ef
|
2
|
|
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort, file dd9e0c66-d3bf-1e9c-e053-3a05fe0a45ef
|
2
|
|
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014, file dd9e0c66-d3c0-1e9c-e053-3a05fe0a45ef
|
2
|
|
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy, file dd9e0c67-254c-1e9c-e053-3a05fe0a45ef
|
2
|
|
Is the rate of virological failure to cART continuing to decline in recent calendar years?, file dd9e0c67-2d20-1e9c-e053-3a05fe0a45ef
|
2
|
|
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide, file dd9e0c68-b32b-1e9c-e053-3a05fe0a45ef
|
2
|
|
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department, file dd9e0c6a-5b60-1e9c-e053-3a05fe0a45ef
|
2
|
|
Occurrence of Acute Pulmonary Embolism in COVID-19—A case series, file dd9e0c6b-0d3f-1e9c-e053-3a05fe0a45ef
|
2
|
|
A Step Closer to the "Fourth 90": A Practical Narrative Review of Diagnosis and Management of Nutritional Issues of People Living with HIV, file fe73b66c-21e4-473f-bc73-1ba0bfebae22
|
2
|
|
Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review, file 03942750-cdeb-419f-8283-680db181a950
|
1
|
|
Monkeypox Virus Infections in Southern Italy: Is There a Risk for Community Spread?, file ca7620bb-b735-4d94-981c-fe8f067a15f1
|
1
|
|
Thoracic aorta graft infection by avibactam-resistant KPC-producing K. pneumoniae treated with meropenem/vaborbactam: a case report and literature review, file d338c33b-e0ed-4d8d-924e-9c95959a103d
|
1
|
|
Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response, file dd9e0c63-e69d-1e9c-e053-3a05fe0a45ef
|
1
|
|
State of the Art of Dual Therapy in 2015, file dd9e0c63-e708-1e9c-e053-3a05fe0a45ef
|
1
|
|
Mortality in migrants living with HIV in western Europe (1997-2013): A collaborative cohort study, file dd9e0c63-e8ba-1e9c-e053-3a05fe0a45ef
|
1
|
|
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage, file dd9e0c66-515c-1e9c-e053-3a05fe0a45ef
|
1
|
|
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus, file dd9e0c66-d18d-1e9c-e053-3a05fe0a45ef
|
1
|
|
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study, file dd9e0c66-d191-1e9c-e053-3a05fe0a45ef
|
1
|
|
Uncommon testicular localization of Disseminated TB: a case report from Mozambique, file dd9e0c66-d3bc-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c66-e54f-1e9c-e053-3a05fe0a45ef
|
1
|
|
A 75-year-old woman presenting with nasal vestibulitis, file dd9e0c66-e635-1e9c-e053-3a05fe0a45ef
|
1
|
|
Direct-acting antivirals for HIV/HCV co-infected individuals: as good as it gets?, file dd9e0c66-e7b2-1e9c-e053-3a05fe0a45ef
|
1
|
|
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL, file dd9e0c66-e7b6-1e9c-e053-3a05fe0a45ef
|
1
|
|
The Revival of an “Old” Marker: CD4/CD8 Ratio, file dd9e0c66-e973-1e9c-e053-3a05fe0a45ef
|
1
|
|
Sofosbuvir-based regimens against an “easy” villain: HCV genotype 2, file dd9e0c66-e976-1e9c-e053-3a05fe0a45ef
|
1
|
|
Rapid improvement in liver fibrosis in HCV-infected patients with or without HIV infection and DAA-induced SVR: A “turning-off” effect of liver inflammation?, file dd9e0c66-f0a7-1e9c-e053-3a05fe0a45ef
|
1
|
|
Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents, file dd9e0c66-f271-1e9c-e053-3a05fe0a45ef
|
1
|
|
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression, file dd9e0c66-f276-1e9c-e053-3a05fe0a45ef
|
1
|
|
Real life experience in treatment of HIV-1/HCV-coinfected patients with pegylated interferon alpha and ribavirin: predictors of SVR., file dd9e0c67-0a80-1e9c-e053-3a05fe0a45ef
|
1
|
|
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL, file dd9e0c67-0fc9-1e9c-e053-3a05fe0a45ef
|
1
|
|
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison, file dd9e0c67-2066-1e9c-e053-3a05fe0a45ef
|
1
|
|
Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance and Herpesvirus Reactivation: A Double Face of Janus?, file dd9e0c67-2222-1e9c-e053-3a05fe0a45ef
|
1
|
|
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR, file dd9e0c67-237f-1e9c-e053-3a05fe0a45ef
|
1
|
|
The elderly and direct antiviral agents: Constraint or challenge?, file dd9e0c67-2693-1e9c-e053-3a05fe0a45ef
|
1
|
|
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen, file dd9e0c67-27f6-1e9c-e053-3a05fe0a45ef
|
1
|
|
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals, file dd9e0c67-27fc-1e9c-e053-3a05fe0a45ef
|
1
|
|
HIV rapid test in a community setting as a strategy to improve access to HIV testing: data from a multicentre experience in Italy, file dd9e0c67-2b5d-1e9c-e053-3a05fe0a45ef
|
1
|
|
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort)., file dd9e0c67-33cc-1e9c-e053-3a05fe0a45ef
|
1
|
|
Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe, file dd9e0c67-3bf2-1e9c-e053-3a05fe0a45ef
|
1
|
|
A 75-year-old woman presenting with nasal vestibulitis, file dd9e0c6a-175f-1e9c-e053-3a05fe0a45ef
|
1
|
|
Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review, file dd9e0c6a-9601-1e9c-e053-3a05fe0a45ef
|
1
|
|
Hepatic encephalopathy in the course of anti-HCV therapy with paritaprevir/ritonavir, ombitasvir, dasabuvir and ribavirin, file dd9e0c6a-97ce-1e9c-e053-3a05fe0a45ef
|
1
|
|
Pulmonary Artery Filling Defects in Covid-19 Patients Revealed Using CT Pulmonary Angiography: A Predictable Complication?, file dd9e0c6b-8cf1-1e9c-e053-3a05fe0a45ef
|
1
|
| Totale |
2.333 |